Ireland - English - HPRA (Health Products Regulatory Authority)

pegasus laboratories ireland limited - phenylpropanolamine hydrochloride - chewable tablet - 15 mg/tablet - phenylpropanolamin

Ireland - English - HPRA (Health Products Regulatory Authority)

fatro s.p.a. - phenylpropanolamine hydrochloride - syrup - 40 milligram(s)/millilitre - phenylpropanolamin

United Kingdom - English - VMD (Veterinary Medicines Directorate)

vetoquinol uk ltd - phenylpropanolamine, phenylpropanolamine hydrochloride - syrup - neurological agent - dogs

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 1 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin hydrochloride 2 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

marlborough pharmaceuticals ltd - doxepin hydrochloride - oral capsule - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - doxepin hydrochloride - oral capsule - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - doxepin hydrochloride - oral capsule - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - doxepin hydrochloride - oral capsule - 50mg

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - chlorpromazine hydrochloride -